MedTrace Logo

Intranasal Esketamine and Fentanyl for Pain in Minor Trauma

NCT03421275 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2020-02-13

No results posted yet for this study

Summary

Intranasal esketamine, fentanyl and placebo are compared in treatment of acute pain in adult patients with minor trauma. Study is blinded randomized placebo-controlled parallel design.

Conditions

  • Acute Pain Due to Trauma

Interventions

DRUG

Esketamine

anesthetic used as analgetic in subanesthetic doses given intranasally

DRUG

Fentanyl Citrate

intravenous fentanyl given intranasally

DRUG

Saline Nasal

intravenous saline given intranasally as placebo

Sponsors & Collaborators

  • Anna Meuronen, MD

    lead OTHER

Principal Investigators

  • Anna Meuronen, MD,PhD · consultant

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2022-12-01
Completion
2022-12-01
FDA Drug
Yes

Countries

  • Finland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03421275 on ClinicalTrials.gov